SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-033960
Filing Date
2023-10-05
Accepted
2023-10-05 16:02:01
Documents
6
Period of Report
2023-12-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14a-2023a.htm PRE 14A 611701
2 GRAPHIC avalo-logoxblk.jpg GRAPHIC 48586
3 GRAPHIC capnetlossgraph.jpg GRAPHIC 222093
4 GRAPHIC captsrgraph.jpg GRAPHIC 204342
5 GRAPHIC proxycards_avalotherapeu001.jpg GRAPHIC 133045
6 GRAPHIC proxycards_avalotherapeu002.jpg GRAPHIC 116010
  Complete submission text file 0001628280-23-033960.txt   1609745
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37590 | Film No.: 231311323
SIC: 2834 Pharmaceutical Preparations